in-vivo
(2)
K2bio
K2bio is a Houston-based preclinical contract research organization (CRO) built on assets acquired from Bellicum Pharmaceuticals, including a certified mouse vivarium. It pairs full-service GLP and non-GLP in vivo and in vitro research with flexible private and shared lab space near the Texas Medical Center, giving early-stage biotech and pharma teams big-company infrastructure on small-company budgets.
Mammoth Biosciences
Mammoth Biosciences is a Brisbane, California biotechnology company co-founded by Nobel laureate Jennifer Doudna that develops ultracompact CRISPR systems for both in vivo gene-editing therapeutics and rapid molecular diagnostics. Its proprietary toolbox of small Cas enzymes (including Cas14 and CasΦ) powers therapeutic partnerships with Regeneron, Vertex and Bayer, while the DETECTR platform brings CRISPR-based disease detection out of the central lab.